Clinical Trial Update: Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) [Phase 2]

View source ↗

Summary

Phase 2 trial of temozolomide for brain metastases from non-small cell lung cancer has completed; the study status is listed as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis | Phase 2 | Status: COMPLETED